Last reviewed · How we verify
JNJ-64991524 Dose Level 2
At a glance
| Generic name | JNJ-64991524 Dose Level 2 |
|---|
| Sponsor | Janssen Research & Development, LLC |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.